| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.34 | 0.02 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.3 | 0.02 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |